NCT02273609 - INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA) | Biotech Hunter

Enrollment

1,524

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

October 31, 2014

Conditions

Atrial Fibrillation and Flutter

Interventions

DRUG

Vitamin K antagonists (acenocoumarol or warfarin)

"INR values of patients treated with acenocoumarol or warfarin in the last 12 months will be recorded according to clinical practice of each center.~No specific recommendation about treatment will be provided by sponsor."